Home › Funds › Lynx1 Capital Management LP › NEUP

Lynx1 Capital Management LP position in NEUP

NEUPHORIA THERAPEUTICS INC · Health Care

Lynx1 Capital Management LP reported holding 875,328 shares of NEUP (NEUPHORIA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.8M, representing 0.44% of its reported portfolio and ranking #9 among its reported holdings. Lynx1 Capital Management LP has disclosed NEUP holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)875.33K sh
Reported value held$3.83M
Portfolio Weight0.44%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's NEUP position evolved

Lynx1 Capital Management LP first disclosed a stake in NEUP in Q4 2024 at 45,806 shares (US$157K). The position peaked in Q2 2026 at 875,328 shares, worth US$3.8M. Across 6 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 875,328 shares valued at US$3.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 45.81K $157.12K New
Q1 2025 45.81K $263.84K Hold
Q2 2025 45.81K $325.22K Hold
Q4 2025 875.23K $3.40M New
Q1 2026 875.33K $3.56M Hold
Q2 2026 875.33K $3.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NEUP and 13F data

NEUP (NEUPHORIA THERAPEUTICS INC) is a Health Care company. 21 other funds we track also report a position in NEUP — the largest reported positions include Merck & Co., Inc. (US$44K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NEUP

All NEUP fund holders →

FAQ

How long has Lynx1 Capital Management LP held NEUP?

Lynx1 Capital Management LP has disclosed NEUP holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

What is Lynx1 Capital Management LP's current position in NEUP?

As of Q2 2026, Lynx1 Capital Management LP holds 875.33K shares of NEUP (NEUPHORIA THERAPEUTICS INC), valued at $3.83M, representing 0.44% of its reported portfolio and ranking #9.

Has Lynx1 Capital Management LP been buying or selling NEUP?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in NEUP. The position peaked in Q2 2026 at 875.33K shares.

Which other funds hold NEUP?

Other major institutional holders of NEUP include Merck & Co., Inc., among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.